What's Going On With Verastem Oncology Stock On Monday?

benzinga.com/news/health-care/25/06/45728052/whats-going-on-with-verastem-oncology-stock-on-monday

Verastem Oncology Inc (NASDAQ:VSTM) released on Monday updated data from the dose escalation phase of the Phase 1/2 trial of GFH375 (known as VS-7375 in the U.S.).
As of May 16, 2025, 23 efficacy-evaluable patients with pancreatic ductal adenocarcinoma (PDAC) and 12 efficacy-evaluable…

This story appeared on benzinga.com, 2025-06-02 16:41:21.
The Entire Business World on a Single Page. Free to Use →